Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
J Am Coll Cardiol. 2010 Aug 31;56(10):774-81. doi: 10.1016/j.jacc.2010.06.014.
We sought to investigate the impact of left ventricular (LV) pacing site on mechanical response to cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy (ICM).
CRT reduces morbidity and mortality in patients with dyssynchronous LV failure; however, variability in response, particularly in ICM patients, poses ongoing challenges. Endocardial biventricular (BiV) stimulation may provide more flexibility in LV site selection and yield more natural transmural activation patterns. Whether this applies to ICM and whether optimal LV endocardial pacing locations vary among ICM patients remain unknown.
Peak rate of LV pressure increase (dP/dt(max)) was measured at baseline, during VDD pacing at the right ventricular apex, and during BiV pacing from the right ventricular apex and 51 +/- 14 different LV endocardial sites in patients with ICM (n = 11). Seven patients already had an epicardial LV lead (CRT) in place, allowing comparison of epicardial BiV stimulation with that using an endocardial site directly transmural to the CRT-coronary sinus lead tip. Electroanatomic 3-dimensional maps with color-coded dP/dt(max) response defined optimal pacing regions delivering >or=85% of maximal increase in dP/dt(max).
Endocardial BiV pacing improved dP/dt(max) over right ventricular apex pacing in all patients (mean increase 241 +/- 38 mm Hg/s; p < 0.0001). In patients with pre-existing CRT leads, LV endocardial versus epicardial pacing at transmural sites yielded equivalent dP/dt(max) values. However, dP/dt(max) at the best endocardial site exceeded that achieved with the pre-implanted CRT device (mean increase 111 +/- 25 mm Hg/s; p = 0.004). An average of approximately 2 optimal endocardial sites were identified for each patient, located at the extreme basal lateral wall (8 of 11 patients) and other regions (9 of 11). Standard mid-LV free wall pacing yielded suboptimal LV function in 73% of patients. Optimal pacing sites were typically located in LV territories remote (9.3 +/- 3.6 cm) from the infarct zone.
CRT delivered at best LV endocardial sites is more effective than via pre-implanted coronary sinus lead pacing. The location of optimal LV endocardial pacing varies among patients with ICM, and individual tailoring may improve CRT efficacy in such patients.
我们旨在探讨左心室(LV)起搏部位对缺血性心肌病(ICM)患者心脏再同步治疗(CRT)机械反应的影响。
CRT 可降低左心室收缩不同步衰竭患者的发病率和死亡率;然而,反应的可变性,特别是在 ICM 患者中,仍然是一个持续存在的挑战。心内膜双心室(BiV)刺激可能在 LV 部位选择方面提供更大的灵活性,并产生更自然的跨壁激活模式。这是否适用于 ICM,以及 ICM 患者之间最佳的 LV 心内膜起搏位置是否不同,目前仍不清楚。
在 11 例 ICM 患者中,在基线时、右心室心尖部 VDD 起搏时和右心室心尖部及 51 +/- 14 个不同 LV 心内膜部位 BiV 起搏时测量 LV 压力升高的峰值速率(dP/dt(max))。7 例患者已经有一个心外膜 LV 导联(CRT),允许比较心外膜 BiV 刺激与直接在心内膜 CRT-冠状窦导联尖端的透壁部位的刺激。彩色编码 dP/dt(max)反应的电解剖 3 维图谱定义了提供 >或=85%的 dP/dt(max)最大增加的最佳起搏区域。
所有患者的心内膜 BiV 起搏均较右心室心尖起搏改善了 dP/dt(max)(平均增加 241 +/- 38 mm Hg/s;p < 0.0001)。在有预先植入的 CRT 导联的患者中,LV 心内膜与透壁部位的心外膜起搏产生等效的 dP/dt(max)值。然而,最佳心内膜部位的 dP/dt(max)超过了预先植入的 CRT 装置(平均增加 111 +/- 25 mm Hg/s;p = 0.004)。平均每个患者确定了大约 2 个最佳的心内膜部位,位于极端的基底外侧壁(11 例中的 8 例)和其他区域(11 例中的 9 例)。标准的 LV 中部游离壁起搏在 73%的患者中导致 LV 功能不佳。最佳起搏部位通常位于距梗死区(9.3 +/- 3.6 cm)较远的 LV 区域。
在最佳的 LV 心内膜部位给予 CRT 比通过预先植入的冠状窦导联起搏更有效。ICM 患者最佳的 LV 心内膜起搏部位的位置各不相同,个体化定制可能会提高此类患者的 CRT 疗效。